MAPT and Alzheimer disease: Stimulation of AD long-term development can be affected by aggressive mutations of tau induced by EVs in various conditions of toxicity: with involvement of EVs generated from pluripotent stem cells [105]; with EVs containing mutations of human tau that results toxic when injected into the mouse brain [106]; with tau isolated from astrocyte EV components and then accumulated by neurons [107].